Form 4 for SLDB Solid Biosciences Inc.

Accepted 2024-01-11 00:00:00 ET · period of report 2024-01-09 · accession 0000950170-24-004007 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-01-11	2024-01-09	SLDB	Tan Kevin	CFO, Treas	S - Sale+OE	$8.20	-3,935	9,308	-30%	-$32.3K
D	2024-01-11	2024-01-09	SLDB	Tan Kevin	CFO, Treas	M - OptEx	—	+11.2K	13.2K	+564%	—
D	2024-01-11	2024-01-09	SLDB	Tan Kevin	CFO, Treas	M - OptEx	$0.00	-11.2K	33.8K	-25%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-01-09	S	D	3,935	$8.20	9,308	D	—	—	(F3) This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The sales do not represent a discretionary trade by Mr. Tan. (F2) Includes 1,993 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on November 30, 2023.
2	Common	Common Stock	2024-01-09	M	A	11,250	—	13,243	D	—	—	(F1) Restricted stock units convert to common stock on a one-for-one basis. (F2) Includes 1,993 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on November 30, 2023.
3	Derivative	Restricted Stock Units	2024-01-09	M	D	11,250	$0.00	33,750	D	— · — to —	11,250 Common Stock	(F1) Restricted stock units convert to common stock on a one-for-one basis. (F4) The restricted stock units were granted on January 9, 2023 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.